CitriPhage™
|
In February 2020, Auxergen, Inc. received notice of allowance of it's patents for an engineered biologic entity to combat Xanthamonas citri. and oyzae, the former infects the U.S. and world citrus crops and the later seriously affects rice production, especially in lesser developed Asian countries.
Pictured Left: Disease control of the plant bacterial pathogens causing citrus canker and rice blight (filed June 2015; CitriPhage™).
|
|
http://www.apsnet.org/publications/apsnetfeatures/Pages/citruscanker.aspx_
|
|
CitriPhage™ has been shown to inhibit and eliminate the Citrus Canker bacterial disease, Xanthomonas citri.
CitriPhage™ has proven effective in both lab and nursery tests. |
Xanthomonas oryzae pv. oryzae causes rice bacterial blight (BB) disease.
Rice blight has high epidemic potential and is destructive to high-yielding cultivars in both temperate and tropical regions especially in Asia. |
